8-K Announcements
6Material company update
Apr 10, 2026·SEC
Material company update
Mar 23, 2026·SEC
Material company update
Mar 19, 2026·SEC
United States Antimony Corporation(UAMY)Earnings, Financials & Key Ratios
UAMY•NYSE
$12.61
$1.77B mkt cap·Price updated May 6, 2026
AboutUnited States Antimony Corporation produces and sells antimony, silver, gold, and zeolite products in the United States and Canada. The company's Antimony division offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper. Its antimony oxide is also used as a color fastener in paints; as a catalyst for the production of polyester resins for fibers and films; as a catalyst for the production of polyethelene pthalate in plastic bottles; as a phosphorescent agent in fluorescent light bulbs; and as an opacifier for porcelains. In addition, this division offers sodium antimonite; and antimony metal for use in bearings, storage batteries, and ordnance; and precious metals. The company's Zeolite division provides zeolite deposits for soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, and animal nutrition applications. Its zeolite products also have applications in catalysts, petroleum refining, concrete, solar energy and heat exchange, desiccants, pellet binding, horse and kitty litter, and floor cleaners, as well as carriers for insecticides, pesticides, and herbicides. United States Antimony Corporation was founded in 1968 and is based in Thompson Falls, Montana.Show more
- Revenue$39M+162.8%
- EBITDA-$8M-548.2%
- Net Income-$4M-150.8%
- EPS (Diluted)-0.04-150.0%
- Gross Margin25.15%+8.4%
- EBITDA Margin-21.55%-146.6%
- Operating Margin-21.55%-34.6%
- Net Margin-11.05%+4.6%
- ROE-5.12%+20.0%
- ROIC-10.33%+25.7%
- Debt/Equity0.00-97.8%
UAMY Key Insights
United States Antimony Corporation (UAMY) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Momentum leader: RS Rating 92 (top 8%)
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 49.6%
✗Weaknesses
- ✗Negative free cash flow
- ✗Shares diluted 13.9% in last year
- ✗Trading more than 30% below 52-week high
- ✗Expensive at 11.1x book value
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
UAMY Price & Volume
United States Antimony Corporation (UAMY) stock price & volume — 10-year historical chart
Loading chart...
UAMY Growth Metrics
United States Antimony Corporation (UAMY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years11.59%
5 Years49.62%
3 Years52.61%
TTM142.65%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-150.78%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-124.72%
Return on Capital
10 Years-11.94%
5 Years-8.75%
3 Years-13.89%
Last Year-9.7%
UAMY Recent Earnings
United States Antimony Corporation (UAMY) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 0/12 qtrs (0%)●Beat Revenue 2/12 qtrs (33%)
Q2 2026Latest
Mar 19, 2026EPS
$0.01
Est $0.01
+0.0%
Revenue
$13M
Est $13M
+2.1%
Q4 2025
Nov 12, 2025EPS
$0.04
Est $0.02
-300.0%
Revenue
$9M
Est $15M
-40.6%
Q3 2025
Aug 12, 2025EPS
$0.00
Est $0.01
-85.7%
Revenue
$11M
Est $13M
-17.0%
Q2 2025
May 8, 2025EPS
$0.00
Est $0.01
-55.3%
Revenue
$7M
Est $8M
-15.9%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 19, 2026 | $0.01vs $0.01+0.0% | $13Mvs $13M+2.1% |
| Q4 2025 | Nov 12, 2025 | $0.04vs $0.02-300.0% | $9Mvs $15M-40.6% |
| Q3 2025 | Aug 12, 2025 | $0.00vs $0.01-85.7% | $11Mvs $13M-17.0% |
| Q2 2025 | May 8, 2025 | $0.00vs $0.01-55.3% | $7Mvs $8M-15.9% |
Based on last 12 quarters of dataView full earnings history →
UAMY Peer Comparison
United States Antimony Corporation (UAMY) competitors in Specialty and Advanced Materials — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 USAS | 2.06B | 6.49 | -15.45 | 5.28% | -56.17% | -122.08% | 0.45 | |
 EXK | 2.74B | 9.31 | -71.62 | 5.93% | -28.43% | -18.44% | 0.25 | |
 HL | 12.17B | 18.15 | 37.04 | 53.03% | 35.55% | 22.55% | 0.12 | |
 CDE | 12.04B | 18.74 | 20.82 | 96.41% | 31.15% | 15.17% | 0.11 | |
 MP | 12.91B | 72.65 | -145.30 | 35.12% | -31.18% | -5.04% | 0.44 | |
 NB | 772.96M | 6.40 | -17.78 | -18% | 0.00 | |||
 CHMG | 322.44M | 67.05 | 21.42 | -6.46% | 6.27% | 0.02 | ||
 FCX | 87.51B | 60.89 | 40.06 | 1.12% | 10.34% | 8.91% | 0.37 |
Compare UAMY vs Peers
United States Antimony Corporation (UAMY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
UAMY Income Statement
United States Antimony Corporation (UAMY) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 10.23M | 9.03M | 8.27M | 5.24M | 7.75M | 11.04M | 8.69M | 14.94M | 39.26M |
| Revenue Growth % | -13.96% | -11.69% | -8.48% | -36.68% | 47.98% | 42.56% | -21.29% | 71.84% | 162.81% |
| Cost of Goods Sold | 9.95M | 9.03M | 9.08M | 5.03M | 6.91M | 9.05M | 12.04M | 11.47M | 29.38M |
| COGS % of Revenue | 97.31% | 99.98% | 109.87% | 96.07% | 89.18% | 81.93% | 138.48% | 76.79% | 74.85% |
| Gross Profit | 275.46K▲ 0% | 1.54K▼ 99.4% | -816.25K▼ 53000.3% | 205.7K▲ 125.2% | 838.61K▲ 307.7% | 2M▲ 138.0% | -3.34M▼ 267.6% | 3.47M▲ 203.7% | 9.87M▲ 184.8% |
| Gross Margin % | 2.69% | 0.02% | -9.87% | 3.93% | 10.82% | 18.07% | -38.48% | 23.21% | 25.15% |
| Gross Profit Growth % | -48.67% | -99.44% | -53000.26% | 125.2% | 307.69% | 138.04% | -267.56% | 203.65% | 184.79% |
| Operating Expenses | 1.24M | -545.49K | 2.94M | 3.51M | 1.5M | 1.65M | 3.72M | 5.86M | 18.33M |
| OpEx % of Revenue | 12.07% | -6.04% | 35.53% | 67.05% | 19.35% | 14.92% | 42.84% | 39.21% | 46.7% |
| Selling, General & Admin | 1.24M | 1.54M | 1.44M | 1.22M | 1.24M | 1.44M | 2.92M | 5.37M | 5.48M |
| SG&A % of Revenue | 12.07% | 17% | 17.4% | 23.33% | 16.01% | 13.06% | 33.64% | 35.96% | 13.96% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -2.08M | 1.5M | 2.29M | 258.3K | 205.74K | 799.57K | 486.11K | 12.85M |
| Operating Income | -959.7K▲ 0% | 547.04K▲ 157.0% | -3.75M▼ 786.2% | -3.3M▲ 12.0% | -660.26K▲ 80.0% | 348.2K▲ 152.7% | -7.07M▼ 2130.1% | -2.39M▲ 66.2% | -8.46M▼ 253.8% |
| Operating Margin % | -9.38% | 6.05% | -45.4% | -63.12% | -8.52% | 3.15% | -81.32% | -16% | -21.55% |
| Operating Income Growth % | -17.54% | 157% | -786.18% | 11.96% | 80.02% | 152.74% | -2130.13% | 66.18% | -253.81% |
| EBITDA | 9.19K | 1.45M | -2.86M | -2.42M | 220.62K | 1.26M | -6.11M | -1.31M | -8.46M |
| EBITDA Margin % | 0.09% | 16.07% | -34.56% | -46.2% | 2.85% | 11.38% | -70.28% | -8.74% | -21.55% |
| EBITDA Growth % | -94.98% | 15700.2% | -296.83% | 15.35% | 109.12% | 469.94% | -585.88% | 78.64% | -548.16% |
| D&A (Non-Cash Add-back) | 968.89K | 904.84K | 895.99K | 885.84K | 880.88K | 909.22K | 959.45K | 1.09M | 0 |
| EBIT | -1.03M | 640.86K | -3.59M | -3.27M | -54.93K | 348.2K | -6.85M | -2.38M | 0 |
| Net Interest Income | -106.1K | -99.97K | -78.34K | -17.99K | -5.54K | 50.78K | 618.76K | 668.54K | 810.55K |
| Interest Income | 873 | 0 | 0 | 0 | 0 | 65.92K | 618.76K | 668.54K | 810.55K |
| Interest Expense | 106.97K | 99.97K | 78.34K | 17.99K | 5.54K | 15.14K | 0 | 0 | 0 |
| Other Income/Expense | -174.69K | -6.14K | 80.79K | 17.94K | 599.79K | 96.53K | 720.71K | 660.41K | 4.12M |
| Pretax Income | -1.13M▲ 0% | 540.89K▲ 147.7% | -3.67M▼ 779.0% | -3.29M▲ 10.5% | -60.47K▲ 98.2% | 444.73K▲ 835.5% | -6.35M▼ 1527.4% | -1.73M▲ 72.7% | -4.34M▼ 150.8% |
| Pretax Margin % | -11.09% | 5.99% | -44.42% | -62.78% | -0.78% | 4.03% | -73.03% | -11.58% | -11.05% |
| Income Tax | 0 | -332.33K | 0 | 0 | 0 | 16.07K | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -61.44% | 0% | 0% | 0% | 3.61% | 0% | 0% | 0% |
| Net Income | -1.13M▲ 0% | 873.23K▲ 177.0% | -3.67M▼ 520.6% | -3.29M▲ 10.5% | -60.47K▲ 98.2% | 428.66K▲ 808.9% | -6.35M▼ 1581.0% | -1.73M▲ 72.7% | -4.34M▼ 150.8% |
| Net Margin % | -11.09% | 9.67% | -44.42% | -62.78% | -0.78% | 3.88% | -73.03% | -11.58% | -11.05% |
| Net Income Growth % | 13.35% | 176.98% | -520.61% | 10.51% | 98.16% | 808.89% | -1580.96% | 72.74% | -150.78% |
| Net Income (Continuing) | -1.13M | 873.23K | -3.67M | -3.29M | -60.47K | 428.66K | -6.35M | -1.73M | -4.34M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.02▲ 0% | 0.01▲ 176.2% | -0.06▼ 541.4% | -0.05▲ 18.6% | -0.00▲ 97.6% | 0.00▲ 427.3% | -0.06▼ 1741.7% | -0.02▲ 72.9% | -0.04▼ 150.0% |
| EPS Growth % | 14.29% | 176.19% | -541.41% | 18.58% | 97.61% | - | - | 72.93% | -150% |
| EPS (Basic) | -0.02 | 0.01 | -0.06 | -0.05 | -0.00 | 0.00 | -0.06 | -0.02 | -0.04 |
| Diluted Shares Outstanding | 67.41M | 68.1M | 69M | 72.51M | 102.84M | 106.29M | 107.55M | 108.59M | 123.64M |
| Basic Shares Outstanding | 67.41M | 67.98M | 69M | 72.51M | 102.84M | 106.29M | 107.55M | 108.59M | 123.64M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
UAMY Balance Sheet
United States Antimony Corporation (UAMY) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.56M | 1.9M | 1.28M | 1.81M | 23.57M | 21.62M | 14.08M | 20.68M | 54.74M |
| Cash & Short-Term Investments | 27.99K | 56.65K | 369.06K | 919.31K | 21.62M | 19.32M | 11.97M | 18.17M | 30.49M |
| Cash Only | 27.99K | 56.65K | 115.51K | 665.1K | 21.36M | 19.06M | 11.9M | 18.17M | 30.49M |
| Short-Term Investments | 0 | 0 | 253.55K | 254.21K | 259.21K | 259.86K | 72.9K | 0 | 0 |
| Accounts Receivable | 362.58K | 838.39K | 284.45K | 238.63K | 891.31K | 784.46K | 625.26K | 1.16M | 4.21M |
| Days Sales Outstanding | 12.94 | 33.87 | 12.56 | 16.64 | 41.99 | 25.92 | 26.25 | 28.26 | 39.17 |
| Inventory | 914.71K | 755.26K | 626.24K | 650.21K | 1.06M | 1.38M | 1.39M | 1.25M | 12.52M |
| Days Inventory Outstanding | 33.54 | 30.52 | 25.16 | 47.18 | 55.76 | 55.47 | 42.03 | 39.64 | 155.54 |
| Other Current Assets | 4.7K | -252.95K | 0 | 0 | 0 | 0 | 0 | 104.16K | 7.51M |
| Total Non-Current Assets | 15.57M | 15.65M | 12.41M | 11.49M | 11.43M | 13.08M | 14.02M | 13.96M | 99.18M |
| Property, Plant & Equipment | 15.13M | 15.23M | 12.19M | 11.23M | 11.13M | 12.13M | 13.45M | 13.46M | 42.42M |
| Fixed Asset Turnover | 0.68x | 0.59x | 0.68x | 0.47x | 0.70x | 0.91x | 0.65x | 1.11x | 0.93x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 57.25K | 0 | 57.27K | 0 | 0 | 0 | 98.78K | 40.49M |
| Other Non-Current Assets | 436.09K | 369.45K | 227.37K | 208.47K | 300K | 954.97K | 564.3K | 408.52K | 16.27M |
| Total Assets | 17.13M▲ 0% | 17.56M▲ 2.5% | 13.69M▼ 22.0% | 13.3M▼ 2.9% | 35M▲ 163.2% | 34.7M▼ 0.9% | 28.09M▼ 19.0% | 34.64M▲ 23.3% | 153.93M▲ 344.3% |
| Asset Turnover | 0.60x | 0.51x | 0.60x | 0.39x | 0.22x | 0.32x | 0.31x | 0.43x | 0.26x |
| Asset Growth % | -3.57% | 2.49% | -22% | -2.88% | 163.19% | -0.86% | -19.04% | 23.31% | 344.32% |
| Total Current Liabilities | 3.93M | 3.52M | 3.98M | 4.48M | 2.07M | 2.22M | 897.46K | 4.01M | 10.18M |
| Accounts Payable | 1.78M | 1.94M | 2.33M | 1.88M | 1.39M | 628.8K | 456.94K | 1.55M | 6.92M |
| Days Payables Outstanding | 65.35 | 78.51 | 93.58 | 136.2 | 73.21 | 25.36 | 13.85 | 49.18 | 86.01 |
| Short-Term Debt | 739.55K | 889.38K | 253.4K | 152.12K | 13.23K | 94.15K | 28.44K | 758.81K | 171.04K |
| Deferred Revenue (Current) | 60.05K | 32.4K | 0 | 756.15K | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 504.91K | 110.09K | 598.04K | 1.06M | 0 | 787.73K | 0 | -626.56K | 10.01M |
| Current Ratio | 0.40x | 0.54x | 0.32x | 0.40x | 11.38x | 9.74x | 15.68x | 5.16x | 5.38x |
| Quick Ratio | 0.16x | 0.33x | 0.16x | 0.26x | 10.87x | 9.12x | 14.14x | 4.85x | 4.15x |
| Cash Conversion Cycle | -18.88 | -14.12 | -55.86 | -72.38 | 24.54 | 56.03 | 54.43 | 18.71 | 108.7 |
| Total Non-Current Liabilities | 2.82M | 2.61M | 1.25M | 1.64M | 563.07K | 611.33K | 1.68M | 2.04M | 2.79M |
| Long-Term Debt | 1.24M | 1.03M | 76.76K | 477.7K | 201.92K | 217.85K | 0 | 195.43K | 14K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 129.01K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.58M | 1.59M | 1.17M | 1.16M | 361.15K | 393.47K | 1.68M | 1.71M | 2.78M |
| Total Liabilities | 6.75M | 6.13M | 5.23M | 6.11M | 2.63M | 2.83M | 2.57M | 6.04M | 12.97M |
| Total Debt | 1.98M | 1.92M | 330.16K | 629.83K | 215.15K | 312K | 28.44K | 1.71M | 185.05K |
| Net Debt | 1.95M | 1.86M | 214.66K | -35.28K | -21.15M | -18.75M | -11.87M | -16.46M | -30.31M |
| Debt / Equity | 0.19x | 0.17x | 0.04x | 0.09x | 0.01x | 0.01x | 0.00x | 0.06x | 0.00x |
| Debt / EBITDA | 215.33x | 1.32x | - | - | 0.98x | 0.25x | - | - | - |
| Net Debt / EBITDA | 212.29x | 1.28x | - | - | -95.86x | -14.91x | - | - | - |
| Interest Coverage | -8.97x | 5.47x | -47.91x | -183.69x | -119.20x | 23.00x | - | - | - |
| Total Equity | 10.38M▲ 0% | 11.42M▲ 10.1% | 8.47M▼ 25.9% | 7.19M▼ 15.1% | 32.37M▲ 350.4% | 31.87M▼ 1.5% | 25.52M▼ 19.9% | 28.6M▲ 12.1% | 140.96M▲ 392.8% |
| Equity Growth % | -8.51% | 10.1% | -25.89% | -15.13% | 350.42% | -1.54% | -19.92% | 12.07% | 392.84% |
| Book Value per Share | 0.15 | 0.17 | 0.12 | 0.10 | 0.31 | 0.30 | 0.24 | 0.26 | 1.14 |
| Total Shareholders' Equity | 10.38M | 11.42M | 8.47M | 7.19M | 32.37M | 31.87M | 25.52M | 28.6M | 140.96M |
| Common Stock | 674.88K | 682.27K | 696.61K | 759.5K | 1.06M | 1.06M | 1.08M | 1.13M | 1.4M |
| Retained Earnings | -26.56M | -25.69M | -29.36M | -32.65M | -32.71M | -33.07M | -39.42M | -41.15M | -45.49M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | -202.98K | 0 | 0 | 0 |
| Accumulated OCI | -8.71M | -9.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
UAMY Cash Flow Statement
United States Antimony Corporation (UAMY) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 716.71K | -656.63K | -11.36K | -1.31M | -2.43M | -249.28K | -4.75M | 2.22M | -9.69M |
| Operating CF Margin % | 7.01% | -7.27% | -0.14% | -24.94% | -31.38% | -2.26% | -54.64% | 14.86% | -24.69% |
| Operating CF Growth % | 68.31% | -191.62% | 98.27% | -11398.58% | -86.23% | 89.75% | -1805.52% | 146.74% | -536.47% |
| Net Income | -1.13M | 873.23K | -3.67M | -3.29M | -60.47K | 428.66K | -6.35M | -1.73M | -4.34M |
| Depreciation & Amortization | 968.89K | 904.84K | 895.99K | 885.84K | 880.88K | 909.22K | 959.45K | 1.09M | 1.17M |
| Stock-Based Compensation | 175K | 175K | 136K | 0 | 47.5K | 61.46K | 0 | 568.59K | 7.08M |
| Deferred Taxes | 0 | -875K | 0 | 0 | 0 | 0 | 687.53K | 0 | 0 |
| Other Non-Cash Items | 306.11K | -1.24M | 1.62M | 431.8K | -475.63K | 412.86K | 2.56M | 195.58K | -13.6M |
| Working Capital Changes | 576.1K | -499.18K | 1.01M | 663.5K | -2.82M | -2.06M | -2.61M | 2.1M | 0 |
| Change in Receivables | 189.54K | -75.81K | 353.27K | 7.46K | -686.93K | -607.45K | -80.57K | -270.26K | -3.1M |
| Change in Inventory | -59.07K | 159.45K | 112.62K | -23.97K | -405.21K | -596.79K | -2.08M | 74.74K | 919.05K |
| Change in Payables | 479.11K | -350.04K | 402.66K | -452.1K | -491.12K | -756.95K | -171.87K | 1.09M | 3.4M |
| Cash from Investing | -365.54K | 900.88K | -392.93K | -243.09K | -653.13K | -1.79M | -1.34M | -42.07K | -87.4M |
| Capital Expenditures | -365.54K | -899.12K | -792.92K | -243.09K | -648.13K | -1.73M | -1.53M | -430.6K | -27.81M |
| CapEx % of Revenue | 3.57% | 9.95% | 9.59% | 4.64% | 8.37% | 15.63% | 17.58% | 2.88% | 70.84% |
| Acquisitions | 0 | 1.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 1.8M | 400K | 0 | 0 | 0 | 0 | 315.63K | -2.49M |
| Cash from Financing | -333.23K | -221.69K | 463.15K | 2.1M | 23.78M | -267.73K | -1.07M | 4.14M | 109.48M |
| Debt Issued (Net) | -211.53K | -239.92K | -114.53K | 299.66K | -186.43K | -64.75K | -283.56K | -103.49K | 0 |
| Equity Issued (Net) | 0 | 0 | 404.2K | 1000K | 1000K | -202.98K | 0 | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | -787.73K | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -202.98K | 0 | 0 | 0 |
| Other Financing | -121.7K | 18.23K | 173.49K | -14.37K | 626.8K | 0 | 0 | 1.48M | 109.48M |
| Net Change in Cash | 17.93K▲ 0% | 22.57K▲ 25.9% | 58.87K▲ 160.9% | 549.61K▲ 833.6% | 20.7M▲ 3665.9% | -2.3M▼ 111.1% | -7.16M▼ 211.1% | 6.32M▲ 188.2% | 12.39M▲ 96.1% |
| Free Cash Flow | 351.16K▲ 0% | -1.56M▼ 543.0% | -804.28K▲ 48.3% | -1.55M▼ 92.6% | -3.08M▼ 98.8% | -1.98M▲ 35.8% | -6.28M▼ 217.8% | 1.79M▲ 128.5% | -37.5M▼ 2195.3% |
| FCF Margin % | 3.43% | -17.22% | -9.73% | -29.58% | -39.75% | -17.89% | -72.23% | 11.98% | -95.52% |
| FCF Growth % | 306.56% | -543.03% | 48.3% | -92.56% | -98.84% | 35.85% | -217.8% | 128.5% | -2195.29% |
| FCF per Share | 0.01 | -0.02 | -0.01 | -0.02 | -0.03 | -0.02 | -0.06 | 0.02 | -0.30 |
| FCF Conversion (FCF/Net Income) | -0.63x | -0.75x | 0.00x | 0.40x | 40.21x | -0.58x | 0.75x | -1.28x | 2.23x |
| Interest Paid | 0 | 0 | 24.23K | 17.99K | 5.54K | 15.14K | 10.52K | 8.87K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
UAMY Key Ratios
United States Antimony Corporation (UAMY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -11% | -10.45% | 8.01% | -36.93% | -41.99% | -0.31% | 1.33% | -22.12% | -6.39% | -5.12% |
| Return on Invested Capital (ROIC) | -4.42% | -5.6% | 3.2% | -25.63% | -31.31% | -5.39% | 2.15% | -39.61% | -13.91% | -10.33% |
| Gross Margin | 4.51% | 2.69% | 0.02% | -9.87% | 3.93% | 10.82% | 18.07% | -38.48% | 23.21% | 25.15% |
| Net Margin | -11.01% | -11.09% | 9.67% | -44.42% | -62.78% | -0.78% | 3.88% | -73.03% | -11.58% | -11.05% |
| Debt / Equity | 0.18x | 0.19x | 0.17x | 0.04x | 0.09x | 0.01x | 0.01x | 0.00x | 0.06x | 0.00x |
| Interest Coverage | -5.08x | -8.97x | 5.47x | -47.91x | -183.69x | -119.20x | 23.00x | - | - | - |
| FCF Conversion | -0.33x | -0.63x | -0.75x | 0.00x | 0.40x | 40.21x | -0.58x | 0.75x | -1.28x | 2.23x |
| Revenue Growth | -9.3% | -13.96% | -11.69% | -8.48% | -36.68% | 47.98% | 42.56% | -21.29% | 71.84% | 162.81% |
UAMY SEC Filings & Documents
United States Antimony Corporation (UAMY) SEC filings — annual & quarterly reports (10-K, 10-Q)
UAMY Frequently Asked Questions
United States Antimony Corporation (UAMY) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
United States Antimony Corporation (UAMY) reported $39.3M in revenue for fiscal year 2025. This represents a 683% increase from $5.0M in 1996.
United States Antimony Corporation (UAMY) grew revenue by 162.8% over the past year. This is strong growth.
United States Antimony Corporation (UAMY) reported a net loss of $4.3M for fiscal year 2025.
Dividend & Returns
United States Antimony Corporation (UAMY) has a return on equity (ROE) of -5.1%. Negative ROE indicates the company is unprofitable.
United States Antimony Corporation (UAMY) had negative free cash flow of $37.5M in fiscal year 2025, likely due to heavy capital investments.
Explore More UAMY
United States Antimony Corporation (UAMY) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates